Multi-Omics to Predict the Blood Pressure Response to Antihypertensives

Clinical trial NCT05917275 · UNKNOWN

Trial details

NCT number: NCT05917275
Sponsor: Radboud University Medical Center
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Primary Hypertension

Start date: 2024-04-04
Primary completion: 2025-10-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.